研究用抗体・試薬の世界市場予測(〜2025):製品別(抗体(タイプ、フォーム、ソース、研究領域)、試薬)、技術別(ウエスタンブロッティング、フローサイトメトリー)、用途別(プロテオミクス、医薬品開発)、エンドユーザー別

◆英語タイトル:Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025
◆商品コード:BT 5482
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年10月27日
◆ページ数:269
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

arketsandmarkets社は研究用抗体・試薬の世界市場が2020年101億ドルから2025年141億ドルまで、年平均6.7%成長すると予測しています。本調査レポートでは、研究用抗体・試薬の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場インサイト、製品別(試薬、抗体)分析、技術別(ウエスタンブロッティング、フローサイトメトリー、酵素免疫測定法、免疫組織化学、免疫蛍光法)分析、用途別(プロテオミクス、医薬品開発、ゲノミクス)分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、委託研究機関)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場インサイト
・研究用抗体・試薬の世界市場規模:製品別(試薬、抗体)
・研究用抗体・試薬の世界市場規模:技術別(ウエスタンブロッティング、フローサイトメトリー、酵素免疫測定法、免疫組織化学、免疫蛍光法)
・研究用抗体・試薬の世界市場規模:用途別(プロテオミクス、医薬品開発、ゲノミクス)
・研究用抗体・試薬の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、委託研究機関)
・研究用抗体・試薬の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.” The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

“Based on product, the reagents segment holds the highest market share during the forecast period.”
Based on product, the research antibodies and reagents market are segmented into reagent and antibodies. The reagent segment accounted for the larger market share in 2019. The reagents market is experiencing notable growth due to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields.

“Based on technology, the flow cytometry segment is expected to register the highest CAGR during the forecast period.”
Based technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. The flow cytometry segment is expected to witness the highest growth during the forecast period. This is mainly due to this technique is its ability to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture. It offers high throughput and the automated quantification of cell features. These factors, along with technological innovations in flow cytometry and growing cancer research, are driving the growth of this segment.

“By application , the proteomics holds the highest market share during the forecast period.”
Based on application, the research antibodies and reagents market is segmented into proteomics, drug development and Genomics. Proteomics held the largest share of the global research antibodies and reagents market in 2019.The growth of the segment is due to as it efficiently maps drug-protein and protein-protein interactions. Moreover, proteomic technologies have minimized the cost, time, and resource requirements for chemical synthesis and biological testing of drugs. Proteomic technologies, such as electrophoresis, ELISA, microarrays, and MS-based proteomics, are highly efficient for analytical laboratory testing.

“By enduser , the pharmaceutical & biotechnology holds the highest market share during the forecast period.”
The research antibodies and reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The pharmaceutical & biotechnology companies held the largest share of the global research antibodies and reagents end-user market in 2019. The large share of this segment is attributed to the wide use of research antibodies in drug development for the identification and quantification of biomarkers and various analytical procedures.

“By Region, The Asia Pacific region is expected to register the highest CAGR during the forecast period.”
The Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR from 2020 to 2025.The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45% and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the research antibodies and reagents market
The key players operating in the researsch antibodies and reagents systems include Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).

Research Coverage:
The report analyzes the research antibodies and reagent market and aims at estimating the market size and future growth potential of this market based on various segments such as product, distribution channel, and region. The report also includes a product portfolio matrix of various research antibodies and reagents products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global research antibodies and reagent market. The report analyzes this market by product and distribution channel.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global research antibodies and reagent market.
• Market Development: Comprehensive information on the lucrative emerging markets by product and distribution channel
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global research antibodies and reagent market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global research antibodies and reagent market.

【レポートの目次】

1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.2.2 MARKETS COVERED 35
FIGURE 1 GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET 35
1.2.3 YEARS CONSIDERED FOR THE STUDY 35
1.3 CURRENCY 36
1.4 STAKEHOLDERS 36
1.5 LIMITATIONS 36
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 2 RESEARCH DESIGN 38
2.1.1 SECONDARY RESEARCH 39
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY RESEARCH 40
FIGURE 3 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Breakdown of primaries 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 6 MARKET SIZING FROM COMPANY REVENUE 43
FIGURE 7 MARKET ANALYSIS APPROACH 44
FIGURE 8 TOP-DOWN APPROACH 44
2.3 DATA TRIANGULATION APPROACH 46
FIGURE 9 DATA TRIANGULATION METHODOLOGY 46
2.4 MARKET SHARE ESTIMATION 47
2.5 ASSUMPTIONS FOR THE STUDY 47
3 EXECUTIVE SUMMARY 48
FIGURE 10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 48
FIGURE 11 RESEARCH ANTIBODIES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 49
FIGURE 12 RESEARCH REAGENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 49
FIGURE 13 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 50
FIGURE 14 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 50
FIGURE 15 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 51
FIGURE 16 GEOGRAPHIC ANALYSIS: RESEARCH ANTIBODIES AND REAGENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 RESEARCH ANTIBODIES AND REAGENTS: MARKET OVERVIEW 53
FIGURE 17 INCREASING R&D EXPENDITURE IN THE LIFE SCIENCE INDUSTRY TO DRIVE MARKET GROWTH 53
4.2 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION 54
FIGURE 18 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RESEARCH ANTIBODIES AND REAGENTS MARKET IN 2019 54
4.3 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 19 CHINA SHOWS THE HIGHEST REVENUE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 55
4.4 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION (2018–2025) 56
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESEARCH ANTIBODIES AND REAGENTS MARKET UNTIL 2025 56
4.5 RESEARCH ANTIBODIES AND REAGENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS 56
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 22 RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing research activity and funding for R&D 58
5.2.1.2 Growing industry-academia collaboration 58
TABLE 1 KEY MARKET DRIVERS: IMPACT ANALYSIS 59
5.2.2 RESTRAINTS 59
5.2.2.1 Quality concerns and a lack of reproducible results 59
TABLE 2 KEY MARKET RESTRAINTS: IMPACT ANALYSIS 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging markets 60
5.2.3.2 Personalized medicine and protein therapeutics 60
FIGURE 23 NUMBER OF PERSONALIZED MEDICINE PRODUCTS, 2008–2016 61
5.2.3.3 Growth in stem cell and neurobiology research 61
5.2.3.4 Increasing focus on biomarker discovery 62
5.2.3.5 Rising interest in outsourcing 62
TABLE 3 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS 62
5.2.4 CHALLENGES 63
5.2.4.1 Cost and time-intensive antibody development processes 63
5.2.4.2 Pricing pressure faced by prominent market players 63
TABLE 4 KEY MARKET CHALLENGES: IMPACT ANALYSIS 63
6 INDUSTRY INSIGHTS 64
6.1 INTRODUCTION 64
6.2 INDUSTRY TRENDS 64
6.2.1 INCREASING RESEARCH ON THERAPEUTIC ANTIBODIES 64
6.2.2 RECOMBINANT ANTIBODIES ARE SUPPORTING THE SMOOTH TRANSITION FROM IN VITRO TO IN VIVO 64
6.2.3 GROWING CONSOLIDATION OF THE LIFE SCIENCE ANTIBODIES AND REAGENTS MARKET 65
TABLE 5 MAJOR ACQUISITIONS IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET 65
6.3 STAKEHOLDER ANALYSIS 66
FIGURE 24 RESEARCH ANTIBODIES AND REAGENTS MARKETS: STAKEHOLDER ANALYSIS (2019) 67
6.4 STRATEGIC BENCHMARKING 68
TABLE 6 PRODUCT PORTFOLIO ANALYSIS 68
6.5 IMPACT OF COVID-19 ON THE RESEARCH ANTIBODIES AND REAGENTS MARKET 68
7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT 70
7.1 INTRODUCTION 71
TABLE 7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 71
7.2 REAGENTS 71
TABLE 8 REAGENTS, BY TYPE 72
TABLE 9 RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 73
TABLE 10 RESEARCH REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 74
7.2.1 MEDIA & SERA 74
7.2.1.1 Media & sera hold the largest share of the reagents market 74
TABLE 11 RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY,
2018–2025 (USD MILLION) 75
7.2.2 STAINS & DYES 75
7.2.2.1 Growth of the life science industry is driving the demand and use of stains & dyes 75
TABLE 12 RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY,
2018–2025 (USD MILLION) 76
7.2.3 FIXATIVES 77
7.2.3.1 Fixative agents are needed to preserve the morphology and antigenicity of target molecules 77
TABLE 13 RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY,
2018–2025 (USD MILLION) 77
7.2.4 BUFFERS 78
7.2.4.1 Wide use in drug development will drive the market for buffers 78
TABLE 14 RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY,
2018–2025 (USD MILLION) 78
7.2.5 SOLVENTS 79
7.2.5.1 Organic solvents see wide use in pharmaceutical processes and assays like IHC 79
TABLE 15 RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY,
2018–2025 (USD MILLION) 79
7.2.6 ENZYMES 80
7.2.6.1 An increase in proteomic and genomic research activity will ensure demand for enzymes 80
TABLE 16 RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY,
2018–2025 (USD MILLION) 80
7.2.7 PROBES 81
7.2.7.1 The versatility, sensitivity, and quantitative capabilities of probes have ensured their use in research 81
TABLE 17 RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY,
2018–2025 (USD MILLION) 81
7.2.8 OTHER REAGENTS 82
TABLE 18 OTHER RESEARCH REAGENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 82
7.3 ANTIBODIES 83
TABLE 19 RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
7.3.1 ANTIBODIES, BY TYPE 84
TABLE 20 ANTIBODIES, BY TYPE 84
TABLE 21 RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 84
7.3.1.1 Primary antibodies 84
7.3.1.1.1 Increasing demand for accurate and reliable antibodies follows the rise in R&D activity and expenditure 84
TABLE 22 PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
7.3.1.2 Secondary antibodies 85
7.3.1.2.1 Versatility and low cost of production have ensured stable growth in the market for secondary antibodies 85
TABLE 23 SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 86
7.3.2 ANTIBODIES, BY FORM 86
TABLE 24 ANTIBODIES, BY FORM 87
TABLE 25 RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION) 87
7.3.2.1 Monoclonal antibodies 88
7.3.2.1.1 Monoclonal antibodies are among the most common tools in biomedical science 88
TABLE 26 MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 88
7.3.2.2 Polyclonal antibodies 89
7.3.2.2.1 Thermo Fisher Scientific and Abcam are major players in the polyclonal antibodies market 89
TABLE 27 POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
7.3.2.3 Recombinant antibodies 90
7.3.2.3.1 Recombinant antibodies provide a high-specificity, high-sensitivity option 90
TABLE 28 RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
7.3.3 ANTIBODIES, BY SOURCE 91
TABLE 29 ANTIBODIES, BY SOURCE 91
TABLE 30 RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION) 92
7.3.3.1 Mice 92
7.3.3.1.1 Mice are the preferred hosts for research-use antibody production 92
TABLE 31 MOUSE ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
7.3.3.2 Rabbits 93
7.3.3.2.1 Rabbits are a cost-effective means of antibody production 93
TABLE 32 RABBIT ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 94
7.3.3.3 Other sources 94
TABLE 33 OTHER ANTIBODY SOURCES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 95
7.3.4 ANTIBODIES, BY RESEARCH AREA 95
TABLE 34 ANTIBODIES, BY RESEARCH AREA 95
TABLE 35 RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 97
7.3.4.1 Oncology 97
7.3.4.1.1 The high prevalence of cancer has boosted research activity in the sector 97
TABLE 36 RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 98
7.3.4.2 Infectious diseases 99
7.3.4.2.1 Rising awareness and growing research activity are key drivers of the market 99
TABLE 37 RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 99
7.3.4.3 Immunology 100
7.3.4.3.1 Antibodies are used to identify protein and peptides to understand infectious disease immunology better 100
TABLE 38 RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 100
7.3.4.4 Neurobiology 101
7.3.4.4.1 Antibody-based approaches are widely used in molecular and cellular neuroscience 101
TABLE 39 RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 101
7.3.4.5 Stem cells 102
7.3.4.5.1 Increasing funding and the growing importance of stem cells in transplantation are key market drivers 102
TABLE 40 RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY,
2018–2025 (USD MILLION) 102
7.3.4.6 Other research areas 103
TABLE 41 RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS,
BY COUNTRY, 2018–2025 (USD MILLION) 104
8 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY 105
8.1 INTRODUCTION 106
TABLE 42 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 106
8.2 WESTERN BLOTTING 106
8.2.1 HIGH ACCURACY, EASE OF INTERPRETATION, AND OTHER ADVANTAGES HAVE PROPELLED THE USE OF WESTERN BLOTTING 106
TABLE 43 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2018–2025 (USD MILLION) 107
8.3 FLOW CYTOMETRY 107
8.3.1 FLOW CYTOMETRY IS THE FASTEST-GROWING TECHNOLOGY SEGMENT OF THE MARKET 107
TABLE 44 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2018–2025 (USD MILLION) 108
8.4 ENZYME-LINKED IMMUNOSORBENT ASSAY 109
8.4.1 ELISA HAS THE POTENTIAL TO SUPERSEDE THE CURRENT GOLD STANDARD FOR COVID-19 TESTING 109
TABLE 45 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2018–2025 (USD MILLION) 110
8.5 IMMUNOHISTOCHEMISTRY 110
8.5.1 COMPLEXITIES OF IHC POSE CHALLENGES TO MARKET GROWTH 110
TABLE 46 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018–2025 (USD MILLION) 111
8.6 IMMUNOFLUORESCENCE 111
8.6.1 IMMUNOFLUORESCENCE HELPS DETERMINE SPECIFIC GENE EXPRESSIONS 111
TABLE 47 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2018–2025 (USD MILLION) 112
8.7 IMMUNOPRECIPITATION 113
8.7.1 RESULTS OBTAINED BY IP CAN BE ANALYZED THROUGH OTHER TECHNOLOGIES 113
TABLE 48 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2018–2025 (USD MILLION) 113
8.8 OTHER TECHNOLOGIES 114
TABLE 49 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 115
9 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION 116
9.1 INTRODUCTION 117
TABLE 50 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 117
9.2 PROTEOMICS 117
9.2.1 PROTEOMICS HOLDS THE LARGEST SHARE OF THE MARKET, BY APPLICATION 117
TABLE 51 TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS 118
TABLE 52 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS,
BY COUNTRY, 2018–2025 (USD MILLION) 119
9.3 DRUG DEVELOPMENT 119
9.3.1 THE DRUG DEVELOPMENT APPLICATIONS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE 119
FIGURE 25 APPLICATION OF ANTIBODIES IN THE DRUG DEVELOPMENT PROCESS 120
TABLE 53 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 121
9.4 GENOMICS 121
9.4.1 GENOMICS IS CURRENTLY AN EMERGING AREA OF RESEARCH APPLICATIONS AND EXPECTED TO SEE GROWTH IN THE COMING YEARS 121
TABLE 54 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS,
BY COUNTRY, 2018–2025 (USD MILLION) 122
10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER 123
10.1 INTRODUCTION 124
TABLE 55 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER,
2018–2025 (USD MILLION) 124
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 124
10.2.1 PHARMA & BIOTECH COMPANIES DOMINATE THE END-USER MARKET 124
TABLE 56 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 125
10.3 ACADEMIC & RESEARCH INSTITUTIONS 125
10.3.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL THE MARKET 125
TABLE 57 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018–2025 (USD MILLION) 126
10.4 CONTRACT RESEARCH ORGANIZATIONS 127
10.4.1 GROWING WORK ON MONOCLONAL ANTIBODIES AND DRUG CONJUGATES AMONG CROS IS AIDING MARKET GROWTH 127
TABLE 58 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 127
11 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION 128
11.1 INTRODUCTION 129
FIGURE 26 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SNAPSHOT (2019) 129
TABLE 59 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 130
11.2 NORTH AMERICA 130
FIGURE 27 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT 131
TABLE 60 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 131
TABLE 61 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY PRODUCT, 2018–2025 (USD MILLION) 132
TABLE 62 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 63 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 64 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 133
TABLE 65 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 133
TABLE 66 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION) 133
TABLE 67 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 134
TABLE 68 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 134
TABLE 69 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 134
11.2.1 US 135
11.2.1.1 The US dominates the North American market in terms of market share 135
TABLE 70 US NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY
2020 (USD BILLION) 135
TABLE 71 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 136
TABLE 72 US: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 73 US: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 74 US: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION) 137
TABLE 75 US: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 137
TABLE 76 US: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 137
TABLE 77 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 138
TABLE 78 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 138
TABLE 79 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER,
2018–2025 (USD MILLION) 138
11.2.2 CANADA 139
11.2.2.1 Rising cancer incidence and a favorable funding scenario will push market growth in Canada 139
TABLE 80 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 140
TABLE 81 CANADA: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 82 CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 83 CANADA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 141
TABLE 84 CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 141
TABLE 85 CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 141
TABLE 86 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 142
TABLE 87 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 142
TABLE 88 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 142
11.3 EUROPE 143
FIGURE 28 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT 144
TABLE 89 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 145
TABLE 90 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145
TABLE 91 EUROPE: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 92 EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 146
TABLE 93 EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 146
TABLE 94 EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 146
TABLE 95 EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 147
TABLE 96 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 147
TABLE 97 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 148
TABLE 98 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 148
11.3.1 GERMANY 148
11.3.1.1 German holds the largest share of the market in Europe 148
TABLE 99 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 149
TABLE 100 GERMANY: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 101 GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 102 GERMANY: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 150
TABLE 103 GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 150
TABLE 104 GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 150
TABLE 105 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 151
TABLE 106 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 151
TABLE 107 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 151
11.3.2 UK 152
11.3.2.1 The market in the UK is characterized by expansions by leading players and growing R&D investments 152
TABLE 108 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 152
TABLE 109 UK: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 110 UK: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 111 UK: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION) 153
TABLE 112 UK: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 154
TABLE 113 UK: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 154
TABLE 114 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 154
TABLE 115 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 155
TABLE 116 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER,
2018 –2025 (USD MILLION) 155
11.3.3 FRANCE 155
11.3.3.1 Infrastructural development and rising research activity support market growth in France 155
TABLE 117 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 156
TABLE 118 FRANCE: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 119 FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 120 FRANCE: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 157
TABLE 121 FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 157
TABLE 122 FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 157
TABLE 123 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 158
TABLE 124 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 158
TABLE 125 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 158
11.3.4 ITALY 159
11.3.4.1 Rising life science R&D and favorable funding scenario are key drivers of the Italian market 159
TABLE 126 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 159
TABLE 127 ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 160
TABLE 128 ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 160
TABLE 129 ITALY: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 160
TABLE 130 ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 161
TABLE 131 ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 161
TABLE 132 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 161
TABLE 133 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 162
TABLE 134 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 162
11.3.5 SPAIN 162
11.3.5.1 Favorable scenario for research initiatives drives the market in Spain 162
TABLE 135 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 163
TABLE 136 SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 163
TABLE 137 SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 163
TABLE 138 SPAIN: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 164
TABLE 139 SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 164
TABLE 140 SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 164
TABLE 141 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 165
TABLE 142 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 165
TABLE 143 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 165
11.3.6 REST OF EUROPE 166
TABLE 144 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY PRODUCT, 2018–2025 (USD MILLION) 166
TABLE 145 REST OF EUROPE: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 167
TABLE 146 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 167
TABLE 147 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 167
TABLE 148 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 168
TABLE 149 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION) 168
TABLE 150 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 168
TABLE 151 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 169
TABLE 152 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 169
11.4 ASIA PACIFIC 170
FIGURE 29 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT 171
TABLE 153 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 172
TABLE 154 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY PRODUCT, 2018–2025 (USD MILLION) 172
TABLE 155 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 172
TABLE 156 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 173
TABLE 157 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 173
TABLE 158 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 173
TABLE 159 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 174
TABLE 160 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 174
TABLE 161 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 174
TABLE 162 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 175
11.4.1 JAPAN 175
11.4.1.1 Japan dominates the APAC market 175
TABLE 163 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 176
TABLE 164 JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 176
TABLE 165 JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 176
TABLE 166 JAPAN: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 177
TABLE 167 JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 177
TABLE 168 JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 177
TABLE 169 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 178
TABLE 170 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 178
TABLE 171 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 178
11.4.2 CHINA 179
11.4.2.1 China is the fastest-growing segment of the overall market 179
TABLE 172 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 180
TABLE 173 CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 180
TABLE 174 CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 180
TABLE 175 CHINA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 181
TABLE 176 CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 181
TABLE 177 CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 181
TABLE 178 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 182
TABLE 179 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 182
TABLE 180 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 182
11.4.3 INDIA 183
11.4.3.1 Strong economic growth and rising demand for pharmaceuticals are key market drivers in India 183
TABLE 181 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 183
TABLE 182 INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 184
TABLE 183 INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 184
TABLE 184 INDIA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 184
TABLE 185 INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 185
TABLE 186 INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 185
TABLE 187 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 185
TABLE 188 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 186
TABLE 189 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 186
11.4.4 REST OF ASIA PACIFIC 186
TABLE 190 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 187
TABLE 191 ROAPAC: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 188
TABLE 192 ROAPAC: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 188
TABLE 193 ROAPAC: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 188
TABLE 194 ROAPAC: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 189
TABLE 195 ROAPAC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 189
TABLE 196 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 189
TABLE 197 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 190
TABLE 198 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 190
11.5 LATIN AMERICA 190
11.5.1 BRAZIL AND MEXICO TO GROW AT HIGH RATES IN THE LATAM MARKET 190
TABLE 199 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY PRODUCT, 2018–2025 (USD MILLION) 191
TABLE 200 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 201 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 192
TABLE 202 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 192
TABLE 203 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 192
TABLE 204 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION) 193
TABLE 205 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 193
TABLE 206 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 193
TABLE 207 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET,
BY END USER, 2018–2025 (USD MILLION) 194
11.6 MIDDLE EAST AND AFRICA 194
11.6.1 MEA HOLDS THE SMALLEST SHARE OF THE MARKET BUT IS EXPECTED TO PROVIDE STRONG GROWTH OPPORTUNITIES 194
TABLE 208 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 195
TABLE 209 MEA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 195
TABLE 210 MEA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 195
TABLE 211 MEA: RESEARCH ANTIBODIES MARKET, BY FORM,
2018–2025 (USD MILLION) 196
TABLE 212 MEA: RESEARCH ANTIBODIES MARKET, BY SOURCE,
2018–2025 (USD MILLION) 196
TABLE 213 MEA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,
2018–2025 (USD MILLION) 196
TABLE 214 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 197
TABLE 215 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 197
TABLE 216 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 197

12 COMPETITIVE LANDSCAPE 198
12.1 OVERVIEW 198
12.2 MATRIX EVALUATION FRAMEWORK 199
FIGURE 30 MATRIX EVALUATION FRAMEWORK: ACQUISITION WAS THE MOST-ADOPTED STRATEGY 199
12.3 RESEARCH ANTIBODIES MARKET SHARE ANALYSIS 200
FIGURE 31 GLOBAL RESEARCH ANTIBODIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 200
12.4 COMPETITIVE LEADERSHIP MAPPING 202
12.4.1 STARS 202
12.4.2 EMERGING LEADERS 202
12.4.3 PERVASIVE COMPANIES 202
12.4.4 EMERGING COMPANIES 202
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING (2019) 203
12.5 COMPETITIVE SITUATION AND TRENDS 204
12.5.1 PRODUCT LAUNCHES 204
TABLE 217 KEY PRODUCT LAUNCHES, 2020 204
12.5.2 EXPANSIONS 204
TABLE 218 KEY EXPANSIONS, 2018–2020 204
12.5.3 ACQUISITIONS 205
TABLE 219 KEY ACQUISITIONS, 2019–2020 205
12.5.4 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 205
TABLE 220 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2019–2020 205
13 COMPANY PROFILES 206
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 THERMO FISHER SCIENTIFIC 206
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 206
13.2 MERCK GROUP 211
FIGURE 34 MERCK GROUP: COMPANY SNAPSHOT (2019) 211
13.3 ABCAM PLC 215
FIGURE 35 ABCAM PLC: COMPANY SNAPSHOT (2019) 215
13.4 BECTON, DICKINSON AND COMPANY 220
FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 220
13.5 CELL SIGNALING TECHNOLOGY 225
13.6 BIO-RAD LABORATORIES 228
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 228
13.7 F. HOFFMANN-LA ROCHE 231
FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019) 231
13.8 AGILENT TECHNOLOGIES 235
FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 235
13.9 DANAHER CORPORATION 239
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 239
13.10 LONZA 242
FIGURE 41 LONZA: COMPANY SNAPSHOT (2019) 242
13.11 GENSCRIPT 246
FIGURE 42 GENSCRIPT: COMPANY SNAPSHOT (2019) 246
13.12 PERKINELMER 250
FIGURE 43 PERKINELMER: COMPANY SNAPSHOT (2019) 250
13.13 BIOLEGEND 253
13.14 ILLUMINA 256
FIGURE 44 ILLUMINA: COMPANY SNAPSHOT (2019) 256
13.15 IMMUNOPRECISE ANTIBODIES 258
FIGURE 45 IMMUNOPRECISE ANTIBODIES: COMPANY SNAPSHOT (2019) 258
13.16 FUJIREBIO DIAGNOSTICS AB 263
13.17 ANALYTIK JENA AG 264
13.18 OMEGA BIO-TEK 265
13.19 DOVETAIL GENOMICS 266
13.20 ATLAS ANTIBODIES 267
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 268
14.1 INSIGHTS OF INDUSTRY EXPERTS 268
14.2 DISCUSSION GUIDE 269
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 275
14.4 AVAILABLE CUSTOMIZATIONS 277
14.5 RELATED REPORTS 277
14.6 AUTHOR DETAILS 278



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[研究用抗体・試薬の世界市場予測(〜2025):製品別(抗体(タイプ、フォーム、ソース、研究領域)、試薬)、技術別(ウエスタンブロッティング、フローサイトメトリー)、用途別(プロテオミクス、医薬品開発)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆